Dubai Telegraph - ZeptoMetrix Launches H5N1 Control With Phage-Like Particle (PLP) Technology

EUR -
AED 4.392152
AFN 77.725587
ALL 96.672854
AMD 453.321241
ANG 2.140553
AOA 1096.536528
ARS 1726.354217
AUD 1.702659
AWG 2.15391
AZN 2.033848
BAM 1.957275
BBD 2.408115
BDT 146.100104
BGN 2.008168
BHD 0.450751
BIF 3541.969294
BMD 1.195786
BND 1.51254
BOB 8.261226
BRL 6.227054
BSD 1.195601
BTN 110.003901
BWP 15.59175
BYN 3.377445
BYR 23437.408869
BZD 2.404612
CAD 1.615896
CDF 2678.561483
CHF 0.916074
CLF 0.026
CLP 1026.642284
CNY 8.316274
CNH 8.309949
COP 4352.661647
CRC 591.5458
CUC 1.195786
CUP 31.688333
CVE 110.34816
CZK 24.311169
DJF 212.515477
DKK 7.466943
DOP 75.116609
DZD 154.547848
EGP 55.98635
ERN 17.936793
ETB 185.990966
FJD 2.624154
FKP 0.867664
GBP 0.866562
GEL 3.222681
GGP 0.867664
GHS 13.061844
GIP 0.867664
GMD 87.292383
GNF 10491.906897
GTQ 9.173914
GYD 250.138509
HKD 9.333768
HNL 31.552779
HRK 7.535726
HTG 156.718106
HUF 380.793919
IDR 20077.249741
ILS 3.699996
IMP 0.867664
INR 109.878519
IQD 1566.280378
IRR 50372.492465
ISK 145.00113
JEP 0.867664
JMD 187.60138
JOD 0.847828
JPY 182.882941
KES 154.2563
KGS 104.572042
KHR 4808.623869
KMF 492.664252
KPW 1076.287842
KRW 1714.135323
KWD 0.366425
KYD 0.996351
KZT 600.612633
LAK 25718.381853
LBP 107067.187834
LKR 369.918778
LRD 221.18669
LSL 18.864417
LTL 3.530846
LVL 0.723319
LYD 7.51066
MAD 10.82726
MDL 20.110155
MGA 5344.027359
MKD 61.830948
MMK 2511.644633
MNT 4265.240494
MOP 9.612344
MRU 47.692942
MUR 53.990114
MVR 18.486994
MWK 2073.162374
MXN 20.62846
MYR 4.696452
MZN 76.243574
NAD 18.864417
NGN 1660.038615
NIO 44.003162
NOK 11.427375
NPR 176.006642
NZD 1.971959
OMR 0.45974
PAB 1.195601
PEN 3.998413
PGK 5.195916
PHP 70.549589
PKR 334.443043
PLN 4.207314
PYG 8023.046318
QAR 4.358485
RON 5.098113
RSD 117.393954
RUB 89.984025
RWF 1744.414623
SAR 4.485017
SBD 9.659173
SCR 16.575561
SDG 719.266256
SEK 10.540765
SGD 1.512418
SHP 0.897149
SLE 29.055949
SLL 25075.037148
SOS 682.114054
SRD 45.444057
STD 24750.35937
STN 24.518478
SVC 10.461884
SYP 13224.88667
SZL 18.858212
THB 37.434099
TJS 11.167016
TMT 4.185252
TND 3.42398
TOP 2.879166
TRY 51.908359
TTD 8.115116
TWD 37.536328
TZS 3067.191445
UAH 51.169262
UGX 4253.205295
USD 1.195786
UYU 45.244097
UZS 14548.964371
VES 428.660821
VND 31090.440337
VUV 142.978985
WST 3.248725
XAF 656.451714
XAG 0.010348
XAU 0.000223
XCD 3.231672
XCG 2.154824
XDR 0.815555
XOF 656.451714
XPF 119.331742
YER 285.072955
ZAR 18.876633
ZMK 10763.513161
ZMW 23.642818
ZWL 385.042658
  • SCS

    0.0200

    16.14

    +0.12%

  • RYCEF

    -0.1700

    16.43

    -1.03%

  • NGG

    0.3700

    85.05

    +0.44%

  • RBGPF

    0.0000

    82.4

    0%

  • CMSC

    -0.0050

    23.695

    -0.02%

  • GSK

    0.5550

    50.655

    +1.1%

  • RELX

    -1.2150

    36.165

    -3.36%

  • BTI

    0.0500

    60.21

    +0.08%

  • VOD

    0.1400

    14.71

    +0.95%

  • RIO

    1.7600

    95.13

    +1.85%

  • BCE

    0.2150

    25.485

    +0.84%

  • BP

    0.3400

    38.04

    +0.89%

  • BCC

    -0.6800

    80.17

    -0.85%

  • CMSD

    0.0092

    24.06

    +0.04%

  • JRI

    -0.0350

    12.955

    -0.27%

  • AZN

    -0.6300

    92.59

    -0.68%

ZeptoMetrix Launches H5N1 Control With Phage-Like Particle (PLP) Technology
ZeptoMetrix Launches H5N1 Control With Phage-Like Particle (PLP) Technology

ZeptoMetrix Launches H5N1 Control With Phage-Like Particle (PLP) Technology

As H5N1 outbreaks continue to rise globally, the need for robust quality control materials has never been greater. ZeptoMetrix's Influenza A H5N1 Quantitative Stock offers laboratories a comprehensive quality control material that requires RNA extraction, unlike traditional naked RNA products. This novel solution includes three encapsulated H5N1 gene segments within a phage-like particle, ensuring realistic validation of extraction, amplification, and detection steps.

Text size:

BUFFALO, NEW YORK / ACCESS Newswire / June 23, 2025 / ZeptoMetrix® is pleased to announce the launch of NATtrol™ Influenza A H5N1 Quantitative Stock, a groundbreaking advancement in molecular diagnostic quality assurance. Leveraging phage-like particle encapsulated RNA technology, this product sets a new standard for accuracy and reliability in avian influenza (H5N1) detection, addressing critical gaps in laboratories' ability to validate end-to-end testing workflows.

"The ongoing H5N1 pandemic highlighted the urgent need for reliable diagnostic tools," said Dr. Karuna Sharma, PhD, Vice President & Chief Scientific Officer of Antylia Diagnostics division. "This launch represents a significant advancement in diagnostic quality control. By encapsulating RNA within a phage-like particle, we enable labs to have confidence in their results at every step. This is not just innovation; it is vital in the fight against H5N1 and other emerging RNA viruses."

NATtrol Influenza A H5N1 Quantitative Stock (Product Code: 0831198) is NATtrol inactivated to enhance stability and provided with precision quantification at 1,000,000 gene copies/mL of each gene segment, verified by digital PCR (dPCR). The ready-to-use 1 mL format integrates seamlessly with ZeptoMetrix's -STQ product line, streamlining workflow adoption.

More information on how to order and additional ZeptoMetrix products can be found at: www.zeptometrix.com

About ZeptoMetrix®

ZeptoMetrix, an Antylia Scientific company, is an established industry leader in the design, development, and delivery of innovative, quality solutions to the infectious disease diagnostics market. Our expertise and abilities in molecular diagnostics, including external quality controls, verification panels, proficiency panels, customized and OEM products/services, have set the industry standard for performance and reliability and make ZeptoMetrix the preferred choice for independent third-party quality control materials.

Product Page: https://www.zeptometrix.com/us/en/nattrol-influenza-a-h5n1-quantitative-stock-1-x-10-ml-15355

Contact Information

Andrew Zenger
Global Product Manager
[email protected]
(716) 715-7417

SOURCE: ZeptoMetrix



View the original press release on ACCESS Newswire

S.Mohideen--DT